Agreement signedPublished 17 Feb 2023

Financial Strategies Acquisition Corp. /
Austin Biosciences Corp.

Financial Strategies Acquisition Corp. agrees to combine with Austin Biosciences Corp.

Terms
Not stated
Stage
Agreement signed
Buy side: Financial Strategies Acquisition Corp.
Buy sideFinancial Strategies Acquisition Corp.
Target: Austin Biosciences Corp.
TargetAustin Biosciences Corp.
Source · 17 Feb 2023
Buy side: Financial Strategies Acquisition Corp.
Buy sideFinancial Strategies Acquisition Corp.
Target: Austin Biosciences Corp.
TargetAustin Biosciences Corp.
01 / BuyerFinancial Strategies Acquisition Corp.
02 / TargetAustin Biosciences Corp.
01

What happened

Financial Strategies Acquisition Corp. agreed to acquire all of Austin Biosciences Corp.’s outstanding capital stock in exchange for 12,500,000 shares of Class A common stock. The share amount is subject to a fairness opinion and a possible adjustment.

The agreement provides for FXCO Merger Sub I, Inc. to merge into Austin Biosciences Corp., which would survive as a wholly-owned subsidiary of Financial Strategies Acquisition Corp.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Financial Strategies Acquisition Corp. agrees to combine with Austin Biosciences Corp.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.